Facio-scapulo-humeral dystrophy
Clinical trials for Facio-scapulo-humeral dystrophy explained in plain language.
Never miss a new study
Get alerted when new Facio-scapulo-humeral dystrophy trials appear
Sign up with your email to follow new studies for Facio-scapulo-humeral dystrophy, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for FSHD: experimental drug AOC 1020 completes early testing
Disease control CompletedThis study tested a new medicine called AOC 1020 in 90 adults with facioscapulohumeral muscular dystrophy (FSHD), a genetic condition that causes muscle weakness. The goal was to check if the drug is safe and how the body processes it. Participants received either the drug or a p…
Matched conditions: FACIO-SCAPULO-HUMERAL DYSTROPHY
Phase 1/2 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
AI spots rare muscle disease from a simple video
Diagnosis CompletedThis completed pilot study tested whether a computer algorithm could diagnose facioscapulohumeral muscular dystrophy (FSHMD) by analyzing video recordings of people's faces. Researchers recorded 17 participants, including patients with FSHMD, other muscle diseases, and healthy co…
Matched conditions: FACIO-SCAPULO-HUMERAL DYSTROPHY
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC